Ares Strategic Mining (TSX.V: ARS, OTC: ARSMF) is Developing the Only Permitted and Producing Fluorspar Mine in the United States, offering a Much-Needed Domestic Source for This Strategic Mineral You may not realize this, but you probably use Fluorspar everyday, and that’s what makes this such an exciting opportunity. Fluorspar is a part of so […]
Revolutionizing the AI frontier, Scope AI Corp. (CSE:SCPE) (OTCQB:SCPCF) pioneers new opportunities in AI and quantum security, unlocking untapped potential beyond the grasp of tech giants.
Discover Scope Carbon (CSE:SCPE), a cutting-edge player in the booming carbon credits market, positioned to transform CO2 capture and monetization. With innovative AI technology and advanced drone capabilities, Scope Carbon is revolutionizing carbon credit certification and efficiency, aiding major corporations in their journey towards Net Zero. Collaborating with Farm Flight for enhanced data analytics, Scope Carbon is a pivotal picks-and-shovels player in the multi-trillion dollar carbon market, offering a diverse range of revenue streams. Dive into the future of carbon offsetting with Scope Carbon, where technology meets sustainability.
There is no excerpt because this is a protected post.
Discover How Avant Technologies Inc. (OTCQB:AVAI) is Poised to Overcome AI’s Biggest Challenges and Unlock Massive Investment Potential by Making Data Centers More Efficient. Issued on behalf of Avant Technologies Inc. The Artificial Intelligence (AI) revolution is not on the horizon—it’s here, transforming our world with an unrelenting force that demands attention. As we stand […]
We’ve reviewed an astounding amount of companies in this sector, and are hot on the trail of a few that we feel could be making some moves soon. If you want to hear more, feel free to enter your email address in the box provided at the top of this page. Thank you
ISSUED ON BEHALF OF ONCOLYTICS BIOTECH Strong breast cancer trial results suggest Oncolytics Biotech (NASDAQ: ONCY) (TSX: ONC) won’t stay under the radar for long. Every now and then, a biotech stock releases remarkable data that signals a major breakthrough, yet for whatever reason… the market is slow to react. For savvy investors, this type […]
There is no excerpt because this is a protected post.
There is no excerpt because this is a protected post.
Discover why Oncolytics Biotech Inc. (NASDAQ:ONCY) (TSX:ONC) is gaining Wall Street’s unanimous STRONG BUY rating. From earning FDA’s Fast Track Designation to showcasing at ASCO 2023, this small biotech firm is poised to make big strides in cancer treatment. Don’t miss your chance to learn more about their promising drug trials and a potential price target of $15.00.
This sector is absolutely enormous, and there’s hundreds of companies out there trying to figure this out. We are busy analysing dozens of companies in this space and if you’d like to hear more, simply enter your email address in the box provided on this page. Thank you
There is no excerpt because this is a protected post.
